Medicines labeled for the same conditions
Alternatives to icotrokinra
4 other medicines are given the same way (oral) and in the same FDA class as icotrokinra or labeled mainly for the same use (psoriasis); the others include 1 retinoid, 1 phosphodiesterase 4 inhibitor and 1 tyrosine kinase 2 inhibitor (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as icotrokinra?
Psoriasis lists all 38 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Icotrokinra | this medicine | none listed | n/a | No | No current entry |
| Acitretinretinoid | Psoriasis | 8 labelers | $2.59 per capsule 10 mg capsule | Yes | No current entry |
| Apremilastphosphodiesterase 4 inhibitor | Psoriasis | none listed | $90.57 per tablet 30 mg tablet | No | No current entry |
| Deucravacitinibtyrosine kinase 2 inhibitor | Psoriasis | none listed | n/a | No | No current entry |
| Methoxsalenpsoralen | Psoriasis | 1 labeler | n/a | Yes | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Icotrokinra: the full record
- label, generics, price, shortages, recalls